Abstract

The atypical cadherins Fat and Dachsous are key regulators of cell growth and animal development. In contrast to classical cadherins, which form homophilic interactions to segregate cells, Fat and Dachsous cadherins form heterophilic interactions to induce cell polarity within tissues. Here, we determine the co-crystal structure of the human homologs Fat4 and Dachsous1 (Dchs1) to establish the molecular basis for Fat-Dachsous interactions. The binding domains of Fat4 and Dchs1 form an extended interface along extracellular cadherin (EC) domains 1-4 of each protein. Biophysical measurements indicate that Fat4-Dchs1 affinity is among the highest reported for cadherin superfamily members, which is attributed to an extensive network of salt bridges not present in structurally similar protocadherin homodimers. Furthermore, modeling suggests that unusual extracellular phosphorylation modifications directly modulate Fat-Dachsous binding by introducing charged contacts across the interface. Collectively, our analyses reveal how the molecular architecture of Fat4-Dchs1 enables them to form long-range, high-affinity interactions to maintain planar cell polarity.

Fat and Dachsous are large cadherins that regulate planar polarity as a receptor:ligand pair. Here, authors determine the structure of the Fat:Dachsous complex to uncover the molecular determinants of binding and posttranslational modification.

Details

Title
Structure of the planar cell polarity cadherins Fat4 and Dachsous1
Author
Medina, Elliot 1   VIAFID ORCID Logo  ; Easa, Yathreb 2 ; Lester, Daniel K. 3 ; Lau, Eric K. 4 ; Sprinzak, David 2   VIAFID ORCID Logo  ; Luca, Vincent C. 5   VIAFID ORCID Logo 

 H. Lee Moffitt Cancer Center & Research Institute, Department of Drug Discovery, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233); University of South Florida, Cancer Biology Ph.D Program, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X) 
 Tel Aviv University, School of Neurobiology, Biochemistry, and Biophysics, The George S. Wise Faculty of Life Sciences, Tel Aviv, Israel (GRID:grid.12136.37) (ISNI:0000 0004 1937 0546) 
 University of South Florida, Cancer Biology Ph.D Program, Tampa, USA (GRID:grid.170693.a) (ISNI:0000 0001 2353 285X); H. Lee Moffitt Cancer Center & Research Institute, Department of Tumor Biology, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233); H. Lee Moffitt Cancer Center & Research Institute, Molecular Medicine Program, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233) 
 H. Lee Moffitt Cancer Center & Research Institute, Department of Tumor Biology, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233); H. Lee Moffitt Cancer Center & Research Institute, Molecular Medicine Program, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233) 
 H. Lee Moffitt Cancer Center & Research Institute, Department of Drug Discovery, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233); H. Lee Moffitt Cancer Center & Research Institute, Molecular Medicine Program, Tampa, USA (GRID:grid.468198.a) (ISNI:0000 0000 9891 5233) 
Pages
891
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2777197158
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.